Flexible Macromolecular Docking
Flexible Macromolecular Docking
批准号:
8697575
负责人:
RUBEN ABAGYAN
金额:
$36.14万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2018-05-31
关键词:
AchievementAddressAffinityAmino AcidsAwardBindingBinding SitesBiologicalBiological AssayBiologyBiomedical ResearchChemicalsCommunitiesComplexComputer softwareComputing MethodologiesDevelopmentDiagnosticDissociationDockingEndocrine System DiseasesEntropyFundingGTP-Binding ProteinsGeometryHealthImmuneInflammationLaboratoriesLeadLettersLicensingLigand BindingLigandsMalignant NeoplasmsMasksMechanicsMediatingMembrane ProteinsMethodsMolecularMolecular ConformationNuclear ReceptorsPathway interactionsPeptidesPerformanceProceduresProteinsProtocols documentationResolutionResource SharingSamplingSideSignal TransductionSiteSoftware ToolsSolutionsStructureSurfaceSystemTherapeuticTimeValidationVariantVertebral columnbasedesignelectron densityflexibilityimprovedinnovationmolecular sizeopen sourceprotein phosphatase inhibitor-2restraintsuccesssynthetic peptideweb-accessible
中文摘要
蛋白质的完全柔性的肽、环或末端与相对结构化的位点的结合
在其分子伴侣的表面上是一种普遍存在的瞬时大分子
介导大多数识别和信号级联的相互作用。当跨越一个
广泛的亲和力,这种相互作用统一涉及结构化和非结构化
合伙人,在彼此不存在的情况下可能作为独立实体存在,
在有限的时间内,导致构象变化,
其它蛋白质进入/离开复合物,以及下游途径的激活或抑制。
蛋白质-肽相互作用的合成肽调节剂通常是有前途的
癌症、炎症和内分泌失调的治疗候选物。
尽管瞬时蛋白质-肽相互作用对于生物医学研究至关重要
和治疗发现,只有一小部分这些复合物是适合的,
实验结构测定因此,只有精确的肽对接才可能导致
在蛋白质-肽相互作用的结构理解方面取得了突破。然而对于更长的肽
超过6-8个氨基酸,构象搜索的压倒性大小和复杂性
空间,不可避免的不准确的结合位点表示,由于诱导拟合,效率低下
或不充分彻底的采样,以及评分函数错误的积累,
通过计算方法精确确定肽结合位姿和相互作用。
本提案旨在显著扩大肽和蛋白质大小的范围,以用于制备肽和蛋白质。
该精确的复杂几何形状预测可以通过全局构象
优化.这一进展将通过追求两个具体目标来实现:(目标1)发展
和优化的可靠的肽交叉对接程序使用化学场增强
随机整体中的结合位点表示和改进的熵计算
内部坐标的构象搜索;和(目标2)扩展开发的协议
具体的生物项目与实验验证的预测几何形状,
肽变体。目标1中提出的创新战略包括使用新的力场,
丰富的结合位点表示与化学领域,和最佳的
用于诱导配合的袋的构象膨胀。目标2的目标包括复合物
A类和B类GPCR及其蛋白质和肽调节剂以及G蛋白αi相互作用
与GEF肽。
实现这一建议的目标将导致在灵活性方面取得突破性进展。
大分子对接它将产生有价值的软件工具、协议和共享资源
对于生物界来说。这也将导致发现新的肽调节剂,
重要的治疗、免疫和诊断靶点。
英文摘要
The binding of a fully flexible peptide, loop, or terminus of a protein to a relatively structured site
on the surface of its molecular partner is a prevalent type of a transient macromolecular
interaction that mediates the majority of recognition and signaling cascades. While spanning a
wide range of affinities, such interactions uniformly involve a structured and an unstructured
partner that may exist as independent entities in the absence of one another and only associate
for a limited period of time resulting in conformational changes, recruitment or dissociation of
other proteins to/from the complex, and activation or inhibition of the downstream pathways.
Synthetic peptide modulators of protein-peptide interactions are frequently promising
therapeutic candidates in cancer, inflammation and endocrine disorders.
Despite the critical importance of transient protein-peptide interactions for biomedical research
and therapeutic discovery, only a small fraction of these complexes are amenable to
experimental structure determination. Therefore, only accurate peptide docking may lead to a
breakthrough in structural understanding of protein-peptide interactions. Yet for peptides longer
than 6-8 amino acids, the overwhelming size and complexity of the conformational search
space, the inevitable inaccuracies in the binding site representation due to induced fit, inefficient
or insufficiently thorough sampling, and accumulation of scoring function errors prohibit the
accurate determination of peptide binding poses and interactions by computational methods.
The present proposal intends to dramatically expand the range of peptide and protein sizes for
which accurate complex geometry prediction can be achieved by global conformational
optimization. This advance will be made by pursuing two Specific Aims: (Aim 1) Development
and optimization of a reliable peptide cross-docking procedure using chemical field-enhanced
binding site representations and improved entropy calculations in the stochastic global
conformational search in internal coordinates; and (Aim 2) Extension of the developed protocol
to specific biological projects with experimental validation of the predicted geometries and
peptide variants. The innovative strategies proposed in Aim 1 include using a new force field,
the enrichment of binding site representations with chemical fields, and the optimal
conformational expansion of the pocket for induced fit. The targets of Aim 2 include complexes
of Class A and B GPCRs with their protein and peptide modulators and G-protein αi interactions
with GEF peptides.
The attainment of the aims of this proposal will lead to breakthrough advances in flexible
macromolecular docking. It will result in valuable software tools, protocols and shared resources
for the biological community. It will also lead to discovery of new peptide modulators of
important therapeutic, immune, and diagnostic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing biomedical challenges with computational mechanics and big data
-
批准号:10402329
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2019
-
负责人:RUBEN ABAGYAN
-
依托单位:
Addressing biomedical challenges with computational mechanics and big data
-
批准号:10612892
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2019
-
负责人:RUBEN ABAGYAN
-
依托单位:
Addressing biomedical challenges with computational mechanics and big data
-
批准号:9918928
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2019
-
负责人:RUBEN ABAGYAN
-
依托单位:
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
-
批准号:7982295
-
项目类别:
-
资助金额:$100.81万
-
财政年份:2010
-
负责人:RUBEN ABAGYAN
-
依托单位:
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
-
批准号:8505499
-
项目类别:
-
资助金额:$86.69万
-
财政年份:2010
-
负责人:RUBEN ABAGYAN
-
依托单位:
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
-
批准号:8298576
-
项目类别:
-
资助金额:$89.83万
-
财政年份:2010
-
负责人:RUBEN ABAGYAN
-
依托单位:
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
-
批准号:8695411
-
项目类别:
-
资助金额:$89.83万
-
财政年份:2010
-
负责人:RUBEN ABAGYAN
-
依托单位:
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
-
批准号:8146958
-
项目类别:
-
资助金额:$87.83万
-
财政年份:2010
-
负责人:RUBEN ABAGYAN
-
依托单位:
Novel Druggable Exosites in Protein Kinases
-
批准号:7226322
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2006
-
负责人:RUBEN ABAGYAN
-
依托单位:
Novel Druggable Exosites in Protein Kinases
-
批准号:7961365
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2006
-
负责人:RUBEN ABAGYAN
-
依托单位:
Novel Druggable Exosites in Protein Kinases
-
批准号:7094359
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2006
-
负责人:RUBEN ABAGYAN
-
依托单位:
Novel Druggable Exosites in Protein Kinases
-
批准号:7414603
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2006
-
负责人:RUBEN ABAGYAN
-
依托单位:
Novel Druggable Exosites in Protein Kinases
-
批准号:7616838
-
项目类别:
-
资助金额:$11.32万
-
财政年份:2006
-
负责人:RUBEN ABAGYAN
-
依托单位:
Macromolecular Docking
-
批准号:6816870
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2004
-
负责人:RUBEN ABAGYAN
-
依托单位:
Flexible Macromolecular Docking
-
批准号:8919382
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2004
-
负责人:RUBEN ABAGYAN
-
依托单位:
Macromolecular Docking
-
批准号:6921382
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2004
-
负责人:RUBEN ABAGYAN
-
依托单位:
Flexible Macromolecular Docking
-
批准号:8118933
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2004
-
负责人:RUBEN ABAGYAN
-
依托单位:
Flexible Macromolecular Docking
-
批准号:9068941
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2004
-
负责人:RUBEN ABAGYAN
-
依托单位:
Flexible Macromolecular Docking
-
批准号:8309243
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2004
-
负责人:RUBEN ABAGYAN
-
依托单位:
Macromolecular Docking
-
批准号:7104447
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2004
-
负责人:RUBEN ABAGYAN
-
依托单位:
海外基金